How useful is uterine artery Doppler ultrasonography in predicting pre-eclampsia and intrauterine growth restriction?

CMAJ. Canadian Medical Association Journal

Volumn 178, Issue 6, 2008, Pages 727-729

  McLeod, Lynne ^a  

^a IWK HEALTH CENTRE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ACCURACY; DOPPLER ECHOGRAPHY; GESTATIONAL AGE; HUMAN; INTRAUTERINE GROWTH RETARDATION; MORBIDITY; NOTE; PREDICTION; PREECLAMPSIA; PREGNANCY COMPLICATION; PREGNANCY OUTCOME; PRENATAL SCREENING; RISK ASSESSMENT; UTERINE ARTERY;

EID: 41149103929     PISSN: 08203946     EISSN: 14882329     Source Type: Journal    
DOI: 10.1503/cmaj.080242     Document Type: Note

References (20)

1. Sibai B, Dekker G, Kupfermine M. Pre-eclampsia. Lancet 2005;365:785-99.
2. Khan KS, Wojdyla D, Say L, et al. WHO analysis of causes of maternal death: a systematic review. Lancet 2006;367:1066-74.
3. Walker JJ. Pre-eclampsia. Lancet 2000;356:1260-5.
4. Khong TY, De Wolf F, Robertson WB, et al. Inadequate maternal vascular response to placentation in pregnancies complicated by pre-eclampsia and small for gestational age infants. Br J Obstet Gynaecol 1986;93:1049-59.
5. Pijnenborg R, Anthony J, Davey DA, et al. Placental bed spiral arteries in the hypertensive disorders ofpregnancy. Br J Obstet Gynaecol 1991;98:648-55.
6. Shanklin DR, Sibai BM. Ultrastructural aspects of pre-eclampsia. I:Placental bed and boundary vessels. Am J Obstet Gynecol 1989;161:735-41.
7. Wen SW, Huang L, Liston R, et al.; Maternal Health Study Group, Canadian Perinatal Surveillance System. Severe maternal morbidity in Canada, 1991-2001. CMAJ 2005;173:759-64.
8. Roberts JM, Cooper DW. Pathogenesis and genetics of pre-eclampsia. Lancet 2001;357:53-6.
9. Barker DJ, Osmond C, Golding J, et al. Growth in utero, blood pressure in childhood and adult life and mortality from cardiovascular disease. BMJ 1989;298:564-7.
10. Campbell S, Pearce JMF, Hackett G, et al. Qualitative assessment of uteroplacental blood flow: Early screening test for high risk pregnancies. Obstet Gynecol 1986;68:649-53.
11. Martin AM, Bindra R, Curcio P, et al. Screening for pre-eclampsia and fetal growth restriction by uterine artery Doppler at 11-14 weeks of gestation. Ultrasound Obstet Gynecol 2001;18:583-6.
12. Gomez O, Martinez JM, Figueras F, et al. Uterine artery Doppler at 11-14 weeks of gestation to screen for hypertensive disorders and associated complications in an unselected population. Ultrasound Obstet Gynecol 2005;26:490-4.
13. Albaiges G, Missfelder-Lobos H, Lees C, et al. One-stage screening for pregnancy complications by color Doppler assessment of the uterine arteries at 23 weeks' gestation. Obstet Gynecol 2000;96:559-64.
14. Spencer K, Yu CK, Cowans NJ, et al. Prediction of pregnancy complications by first trimester maternal serum PAPP-A and free beta-hCG and with second trimester uterine artery Doppler. Prenat Diagn 2005;25:949-53.
15. Papageorghiou AT, Yu CKH, Bindra R, et al. Multicentre screening for pre-eclampsia and fetal growth restriction by transvaginal uterine artery Doppler at 23 weeks of gestation. Ultrasound Obstet Gynecol 2001;18:441-9.
16. Cnossen JS, Morris RK, ter Riet G, et al. Use of uterine artery Doppler ultrasonography to predict pre-eclampsia and intrauterine growth restriction: a systematic review and bivariable meta-analysis. CMAJ 2008;178:701-11.
17. Pilalis A, Souka P, Antsaklis P, et al. Screening for pre-eclampsia and fetal growth restriction by uterine artery Doppler and PAPP-A at 11-14 weeks' gestation. Ultrasound Obstet Gynecol 2007;29:135-40.
18. Spencer K, Cowans NJ, Chefetz I, et al. First trimester maternal serum PP-13, PAPP-A and second trimester uterine artery Doppler pulsatility index as markers of pre-eclampsia. Ultrasound Obstet Gynecol 2007;29:128-34.
19. Raty R, Koskinen P, Alanen A, et al. Prediction of pre-eclampsia with maternal midtrimester total renin, inhibin A, AFP, and free beta hCG levels. Prenat Diagn 1999;19:122-7.
20. Yaron Y, Cherry M, Kramer RL. Second trimester maternal serum screening: maternal serum alpha fetoprotein, beta chorionic gonadotropin, estriol, and their various combinations as predictors of pregnancy outcome. Am J Obstet Gynecol 1999;181:968-74.